Orthofix' BREG wins Novation deal:
This article was originally published in Clinica
BREG has won a three-year contract to supply US group purchasing organisation (GPO) Novation with its line of Polar Care cold therapy products. The agreement takes effect on January 1 2006. Huntersville, North Carolina-based BREG, which was acquired by orthopaedics group Orthofix International in 2003, reported sales of $18.0m in the Americas region for the third quarter of 2005.
You may also be interested in...
OIG will focus on successful drugs that have been repurposed as orphans, noting nine of the 10 top selling drugs have both orphan and non-orphan indications.
Switzerland’s SIX exchange-listed drug development company, Basilea, is moving two new oncology candidates along its R&D pipeline, supported by strong revenues from two partnered anti-infective products.
Recommendations from the Alliance for Regenerative Medicine aim to improve cross-border healthcare to ensure patients can access advanced therapies.